PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-63.74%
Negative revenue growth while JHX stands at 3.38%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-73.24%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-99.92%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-99.92%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-101.60%
Negative net income growth while JHX stands at 212.45%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-102.14%
Negative EPS growth while JHX is at 208.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-102.16%
Negative diluted EPS growth while JHX is at 208.33%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.98%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.87%
Reduced diluted shares while JHX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-121.11%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-144.54%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while JHX shows 1.39%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.96%
Inventory shrinking or stable vs. JHX's 6.51%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
1.76%
Positive asset growth while JHX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-3.50%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
1.28%
We have some new debt while JHX reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-53.75%
We cut SG&A while JHX invests at 2.27%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.